Terence L. Thomas

Terence L. Thomas

Auto-generated profile, based on publicly available information

Terence L. Thomas

Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2022 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
TTTerence L. Thomas
Terence L. Thomas
GGGraham S. Goh
Graham S. Goh
MNMatthew K. Nguyen
Matthew K. Nguyen
JLJess H. Lonner
Jess H. Lonner

4 March 2023 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
CAChibuzo C. Anene
Chibuzo C. Anene
TTTerence L. Thomas
Terence L. Thomas
JMJonas L. Matzon
Jonas L. Matzon
CJChristopher M. Jones
Christopher M. Jones

25 August 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
TTTerence L. Thomas
Terence L. Thomas
PKPurab D. Kothari
Purab D. Kothari
CBColin M. Baker
Colin M. Baker
STSaad Tarabichi
Saad Tarabichi
SCSean C. Clark
Sean C. Clark
GGGraham S. Goh
Graham S. Goh

22 July 2022 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
GGGraham S. Goh
Graham S. Goh
NSNoam Shohat
Noam Shohat
MAMohammad S. Abdelaal
Mohammad S. Abdelaal
ISIlan Small
Ilan Small
TTTerence Thomas
Terence Thomas
JPJavad Parvizi
Javad Parvizi
Background: Increased serum glucose variability has been proposed as a risk factor for perioperative morbidity and mortality. Given the greater surgical complexity and complication risk of revision total joint arthroplasty (TJA), previous findings may not be generalizable to the revision population. The purpose of this study was to investigate the association between glucose variability and postoperative complications following aseptic revision TJA. Methods: We identified 1,983 patients who underwent an aseptic revision TJA (636 total knee arthroplasties [TKAs] and 1,347 total hip arthroplasties [THAs]) from 2001 to 2019. Patients with ≥2 postoperative glucose values per day or ≥3 values during hospitalization were included in this study. Glucose variability was assessed using the coefficient of variation (COV). Outcomes included length of hospital stay, 90-day complications, mortality, and periprosthetic joint infection (PJI) as defined by the 2018 International Consensus Meeting criteria. Multivariate regression was used to determine the association between glucose variability and each end point, using COV as continuous and categorical variables (that is, COV tertiles). Results: Patients with high glycemic variability were at 1.7 times greater risk for 90-day complications (odds ratio [OR], 1.664 [95% confidence interval (CI), 1.266 to 2.188]; p < 0.001) and 2 times greater risk for PJI at a minimum 1-year follow-up (OR, 1.984 [95% CI, 1.270 to 3.100]; p = 0.003). The risk of 90-day complications increased by 2.2% (OR, 1.022 [95% CI, 1.012 to 1.032]; p < 0.001) and the risk of PJI increased by 1.8% (OR, 1.018 [95% CI, 1.003 to 1.034]; p = 0.013) for every percentage-point increase in COV. Patients with higher glucose variability also had a longer length of stay (beta, 1.028 days [95% CI, 0.590 to 1.466 days]; p < 0.001). These associations were independent of age, sex, body mass index, Charlson Comorbidity Index, involved joint, operative time, history of diabetes, and mean glucose levels. Conclusions: Higher glucose variability was associated with an increased risk of medical complications and PJI following aseptic revision TJA. Patients undergoing these complex procedures should have glucose levels monitored closely in the perioperative period. Future studies should evaluate the utility of continuous glucose monitoring in this high-risk population. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

11 November 2023 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
TTTerence L. Thomas
Terence L. Thomas
RMRahul Muchintala
Rahul Muchintala
CCConnor R. Crutchfield
Connor R. Crutchfield
KPKyle Plusch
Kyle Plusch
CJChristopher M. Jones
Christopher M. Jones
AIAsif M. Ilyas
Asif M. Ilyas
Intramedullary screw fixation has emerged as a popular approach for the treatment of displaced metacarpal fractures. The purpose of this study was to investigate the functional and radiographic outcomes of a newly designed, headless noncompressive fully threaded intramedullary nail (TIMN) for the treatment of metacarpal fractures. A retrospective chart review was performed on patients who were treated with the INnate TIMN (ExsoMed) at a single academic institution with a minimum of 1-year follow-up. Patient-reported functional outcomes included Quick Disabilities for the Arm, Shoulder, and Hand (QuickDASH) questionnaires, return to work and physical activity time, and overall satisfaction. Radiographs were retrospectively reviewed to determine radiographic union, change in angulation, and metacarpal shortening. A total of 49 patients (58 fractures) with a mean age of 36 years (range: 17–75 years) were included. The mean follow-up time was 2.7 years (range: 1.4–4.3 years). Overall, the mean patient satisfaction rating was 4.9 of 5 (range: 3–5). The mean return to work time was 7.2 weeks (range: 0.14–28 weeks), and the mean return to sport or activity was 8.3 weeks (range: 1–28 weeks). Average QuickDASH scores across all patients were 4 (range: 0–56.9). The median radiographic healing time was 6.1 weeks (range: 4.7–15.4 weeks). Mean postoperative shortening in the fifth metacarpal fracture was 3 mm (range: −4.2 to 8 mm) at the initial postoperative visit and 3.6 mm (range: −3.3 to 7.9 mm) at the final radiographic follow-up. Subgroup analysis showed that postoperative shortening was similar, regardless of the fracture pattern. The following four complications were reported: one case of persistent pain and stiffness, one case of carpal tunnel syndrome, one nonunion, and one fractured intramedullary nail. Our findings suggest that the TIMN allows for a reliable return to work and physical activity, high patient satisfaction, low complication rate, and minimal shortening at the final radiographic follow-up. Therapeutic IV.

10 September 2024 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
PNPravarut Nithagon
Pravarut Nithagon
SRSanjeev Rampam
Sanjeev Rampam
TTTerence L. Thomas
Terence L. Thomas
GGGraham S. Goh
Graham S. Goh
Background: Despite the importance of sleep for physiological function, rehabilitation, and recovery, sleep quality after total joint arthroplasty (TJA) remains poor. The objective of this systematic review was to identify, summarize, and evaluate postoperative interventions aimed at improving sleep quality after TJA. Methods: A systematic review of PubMed (MEDLINE) and Scopus (Embase, MEDLINE, COMPENDEX) from inception to April 2024 was conducted (PROSPERO ID: CRD42023447317). Randomized controlled trials on interventions to improve sleep quality were included. Sleep outcomes, including the Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Patient-Reported Outcome Measurement Information System—Sleep Disturbance, Numeric Rating Scale sleep scores,l9 were extracted. Descriptive statistics were used to analyze the available data. Results: Of the 1,549 articles identified, seven randomized trials with a total of 840 patients were included (394 total hip arthroplasties [THA], 446 total knee arthroplasties [TKA]). Pittsburgh Sleep Quality Index was the most commonly used outcome for assessing sleep quality. Among THA studies, zolpidem, combined fascia iliaca compartment block (FICB) and dexmedetomidine (DEX), and perioperative methylprednisolone were shown to markedly improve postoperative sleep quality. Neither topical cannabidiol nor topical essential oil was found to improve postoperative sleep quality after TKA. Melatonin had no effect on sleep outcomes after TJA. Conclusion: Zolpidem, FICB + DEX, and perioperative methylprednisolone are effective interventions to improve sleep quality after THA. Topical cannabis, topical essential oil, and melatonin did not improve sleep quality. No effective sleep interventions for TKA patients were identified. Improving sleep quality remains a potential therapeutic goal to improve patient satisfaction after TJA. Continued investigation on this topic is therefore necessary.